Skip to main content

04.01.2024 | Commentary

Re-examining What the Results of “a Measurement of Oxygen Level in Tissues” Really Mean

verfasst von: Harold M. Swartz, Ann Barry Flood

Erschienen in: Molecular Imaging and Biology

Einloggen, um Zugang zu erhalten

Abstract

Within this special issue, many eminent investigators report on measurements of oxygen (O2) levels in tissues. Given the complexities of spatial and temporal heterogeneities of O2 in tissues and its many sources, this commentary draws attention to what such measurements do and do not actually assess regarding O2 levels in tissues. Given this limitation, it also discusses how these results can be used most effectively. To provide a convenient mechanism to discuss these issues more fully, this analysis focuses on measurements using EPR oximetry, but these considerations apply to all other techniques. The nature of the delivery of O2 to tissues and the mechanisms by which O2 is consumed necessarily result in very different levels of O2 within the volume of each voxel of a measurement. Better spatial resolution cannot fully resolve the problem because the variations include O2 gradients within each cell. Improved resolution of the time-dependent variation in O2 is also very challenging because O2 levels within tissues can have fluctuations of O2 levels in the range of milliseconds, while most methods require longer times to acquire the data from each voxel. Based on these issues, we argue that the values obtained inevitably are complex aggregates of averages of O2 levels across space and time in the tissue. These complexities arise from the complex physiology of tissues and are compounded by the limitations of the technique and its ability to acquire data. However, one often can obtain very meaningful and useful results if these complexities and limitations are taken into account. We illustrate this, using results obtained with in vivo EPR oximetry, especially utilizing its capacity to make repeated measurements to follow changes in O2 levels that occur with interventions and/or over time.
Fußnoten
1
For simplicity, we omit details about how each sensor type was administered to the animal or subject, i.e., what the volumes administered and concentrations were needed for in vivo measurements of O2. Although these are important pharmacological considerations (e.g., how to scale concentrations for human applications and whether this scaling would affect clearance, toxicity, etc. for applications in humans), this is beyond the scope of this discussion. See references for primary studies with such details.
 
2
For simplicity, we refer only to US regulations. There are parallel regulatory processes that are needed for approval for use in humans in each country. To date, trityls have been approved for limited investigational use only, but not for use in EPRI.
 
Literatur
1.
Zurück zum Zitat Harrison D, Vaupel P (2014) Heterogeneity in tissue oxygenation: from physiological variability in normal tissues to pathophysiological chaos in malignant tumors. Adv Exp Med Biol 812:25–31PubMedCrossRef Harrison D, Vaupel P (2014) Heterogeneity in tissue oxygenation: from physiological variability in normal tissues to pathophysiological chaos in malignant tumors. Adv Exp Med Biol 812:25–31PubMedCrossRef
2.
Zurück zum Zitat Vaupel P, Flood AB, Swartz HM (2021) Oxygenation status of malignant tumors vs. normal tissues: critical evaluation and updated data source based on direct measurements with pO2 microsensors. Appl Magn Reson 51:1481–1487CrossRef Vaupel P, Flood AB, Swartz HM (2021) Oxygenation status of malignant tumors vs. normal tissues: critical evaluation and updated data source based on direct measurements with pO2 microsensors. Appl Magn Reson 51:1481–1487CrossRef
3.
Zurück zum Zitat Khan N, Shen J, Chang TY et al (2003) Plasma membrane cholesterol: a possible barrier to intracellular oxygen in normal and mutant CHO cells defective in cholesterol metabolism. Biochem 42:23–29CrossRef Khan N, Shen J, Chang TY et al (2003) Plasma membrane cholesterol: a possible barrier to intracellular oxygen in normal and mutant CHO cells defective in cholesterol metabolism. Biochem 42:23–29CrossRef
4.
Zurück zum Zitat Levick JR, Michel CC (2010) Microvascular fluid exchange and the revised Starling principle. Cardiovasc Res 87:198–210PubMedCrossRef Levick JR, Michel CC (2010) Microvascular fluid exchange and the revised Starling principle. Cardiovasc Res 87:198–210PubMedCrossRef
5.
Zurück zum Zitat Braun RD, Lanzen JL, Dewhirst MW (1999) Fourier analysis of fluctuations of oxygen tension and blood flow in R3230Ac tumors and muscle in rats. Amer J Physiol 277(2 Pt 2):H551-568PubMed Braun RD, Lanzen JL, Dewhirst MW (1999) Fourier analysis of fluctuations of oxygen tension and blood flow in R3230Ac tumors and muscle in rats. Amer J Physiol 277(2 Pt 2):H551-568PubMed
6.
Zurück zum Zitat Griffith TM (1996) Temporal chaos in the microcirculation. Cardiovas Res 3:342–358CrossRef Griffith TM (1996) Temporal chaos in the microcirculation. Cardiovas Res 3:342–358CrossRef
8.
Zurück zum Zitat Kimura H, Braun RD, Ong ET et al (1996) Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma. Cancer Res 56:5522–5528PubMed Kimura H, Braun RD, Ong ET et al (1996) Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma. Cancer Res 56:5522–5528PubMed
10.
Zurück zum Zitat Hall EJ, Giaccia AJ (2018) Radiobiology for the radiologist, 8th edn. Wolters Kluwer Health, Inc.: Alphen aan den Rijn, the Netherlands Hall EJ, Giaccia AJ (2018) Radiobiology for the radiologist, 8th edn. Wolters Kluwer Health, Inc.: Alphen aan den Rijn, the Netherlands
12.
Zurück zum Zitat Springett R, Swartz HM (2007) Measurements of oxygen in vivo: overview and perspectives on methods to measure oxygen within cells and tissues. Antiox Redox Signal 9:1295–1301CrossRef Springett R, Swartz HM (2007) Measurements of oxygen in vivo: overview and perspectives on methods to measure oxygen within cells and tissues. Antiox Redox Signal 9:1295–1301CrossRef
14.
Zurück zum Zitat Swartz HM, Flood AB, Schaner PE et al (2020) How best to interpret measures of levels of oxygen in tissues to make them effective clinical tools for care of patients with cancer and other oxygen-dependent pathologies. Physiol Rep 8(e14541):1–20 Swartz HM, Flood AB, Schaner PE et al (2020) How best to interpret measures of levels of oxygen in tissues to make them effective clinical tools for care of patients with cancer and other oxygen-dependent pathologies. Physiol Rep 8(e14541):1–20
15.
Zurück zum Zitat Swartz HM, Flood AB, Williams BB et al (2021) What is the meaning of an oxygen measurement? Analysis of methods purporting to measure oxygen in targeted tissues. Adv Exp Med Bio 1269:301–308CrossRef Swartz HM, Flood AB, Williams BB et al (2021) What is the meaning of an oxygen measurement? Analysis of methods purporting to measure oxygen in targeted tissues. Adv Exp Med Bio 1269:301–308CrossRef
16.
Zurück zum Zitat Swartz HM, Vaupel P, Williams BB et al (2020) ‘Oxygen level in a tissue’ – what do available measurements really report? Adv Exp Med Bio 1232:145–153CrossRef Swartz HM, Vaupel P, Williams BB et al (2020) ‘Oxygen level in a tissue’ – what do available measurements really report? Adv Exp Med Bio 1232:145–153CrossRef
17.
Zurück zum Zitat Jansson T, Persson HW, Lindström K (2002) Movement artefact suppression in blood perfusion measurements using a multifrequency technique. Ultrasound Med Biol 28(1):69–79PubMedCrossRef Jansson T, Persson HW, Lindström K (2002) Movement artefact suppression in blood perfusion measurements using a multifrequency technique. Ultrasound Med Biol 28(1):69–79PubMedCrossRef
18.
Zurück zum Zitat Briers DJ (2001) Laser Doppler, speckle and related techniques for blood perfusion mapping and imaging. Physiol Measure 22:R35-66CrossRef Briers DJ (2001) Laser Doppler, speckle and related techniques for blood perfusion mapping and imaging. Physiol Measure 22:R35-66CrossRef
19.
Zurück zum Zitat Song X, Liang B, Wang C, Shi S (2020) Clinical value of color Doppler ultrasound combined with serum CA153, CEA and TSGF detection in the diagnosis of breast cancer. Exp Ther Med 20:1822–1828PubMedPubMedCentralCrossRef Song X, Liang B, Wang C, Shi S (2020) Clinical value of color Doppler ultrasound combined with serum CA153, CEA and TSGF detection in the diagnosis of breast cancer. Exp Ther Med 20:1822–1828PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Xiao W, Wang R-S, Handy DE, Loscalzo J (2018) NAD(H) and NADP(H) redox couples and cellular energy metabolism. Antioxid Redox Signal 28:251–272PubMedPubMedCentralCrossRef Xiao W, Wang R-S, Handy DE, Loscalzo J (2018) NAD(H) and NADP(H) redox couples and cellular energy metabolism. Antioxid Redox Signal 28:251–272PubMedPubMedCentralCrossRef
21.
Zurück zum Zitat Reeves KM, Song PN, Angermeier A et al (2022) 18F-FMISO PET imaging identifies hypoxia and immunosuppressive tumor microenvironments and guides targeted evofosfamide therapy in tumors refractory to PD-1 and CTLA-4 inhibition. Clin Cancer Res 28:327–337PubMedCrossRef Reeves KM, Song PN, Angermeier A et al (2022) 18F-FMISO PET imaging identifies hypoxia and immunosuppressive tumor microenvironments and guides targeted evofosfamide therapy in tumors refractory to PD-1 and CTLA-4 inhibition. Clin Cancer Res 28:327–337PubMedCrossRef
22.
Zurück zum Zitat Zhao D, Pacheco-Torres J, Hallac R et al (2015) Dynamic oxygen challenge evaluated by NMR T1 and T2*–insights into tumor oxygenation. NMR Biomed 28(8):937–947PubMedPubMedCentralCrossRef Zhao D, Pacheco-Torres J, Hallac R et al (2015) Dynamic oxygen challenge evaluated by NMR T1 and T2*–insights into tumor oxygenation. NMR Biomed 28(8):937–947PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Swartz HM, Swartz SM (1983) Biochemical and biophysical applications of electron spin resonance. In: Glick D (ed) Methods of biochemical analysis. John Wiley & Sons, New York, NY, pp 207–323CrossRef Swartz HM, Swartz SM (1983) Biochemical and biophysical applications of electron spin resonance. In: Glick D (ed) Methods of biochemical analysis. John Wiley & Sons, New York, NY, pp 207–323CrossRef
24.
Zurück zum Zitat Baranska A, Shawket A, Jouve M et al (2018) Unveiling skin macrophage dynamics explains both tattoo persistence and strenuous removal. J Exp Med 215:1115–1133PubMedPubMedCentralCrossRef Baranska A, Shawket A, Jouve M et al (2018) Unveiling skin macrophage dynamics explains both tattoo persistence and strenuous removal. J Exp Med 215:1115–1133PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat Takausagi Y, Naz S, Takakusagi K et al (2018) A multimodal molecular imaging study evaluates pharmacological alteration of the tumor microenvironment to improve radiation response. Cancer Res 78:6828–6837CrossRef Takausagi Y, Naz S, Takakusagi K et al (2018) A multimodal molecular imaging study evaluates pharmacological alteration of the tumor microenvironment to improve radiation response. Cancer Res 78:6828–6837CrossRef
29.
Zurück zum Zitat Vaupel P (2009) Pathophysiology of solid tumors. In: Molls M, Vaupel P, Nieder C, Anscher MS, (eds) The impact of tumor biology on cancer treatment and multidisciplinary strategies. Medical radiology. Springer Berlin, Heidelberg, p 51–92 Vaupel P (2009) Pathophysiology of solid tumors. In: Molls M, Vaupel P, Nieder C, Anscher MS, (eds) The impact of tumor biology on cancer treatment and multidisciplinary strategies. Medical radiology. Springer Berlin, Heidelberg, p 51–92
30.
Zurück zum Zitat Swartz HM, Williams BB, Zaki B et al (2014) Clinical EPR: unique opportunities and some challenges. Academ Radiol 21:197–206CrossRef Swartz HM, Williams BB, Zaki B et al (2014) Clinical EPR: unique opportunities and some challenges. Academ Radiol 21:197–206CrossRef
31.
Zurück zum Zitat Swartz HM, Khan N, Buckey J et al (2004) Clinical applications of EPR: overview and perspectives. NMR Biomed 17:335–351PubMedCrossRef Swartz HM, Khan N, Buckey J et al (2004) Clinical applications of EPR: overview and perspectives. NMR Biomed 17:335–351PubMedCrossRef
32.
Zurück zum Zitat Khan N, Hou H, Hein P et al (2005) Black magic and EPR oximetry: from lab to initial clinical trials. Adv Exp Med Biol 566:119–125PubMedCrossRef Khan N, Hou H, Hein P et al (2005) Black magic and EPR oximetry: from lab to initial clinical trials. Adv Exp Med Biol 566:119–125PubMedCrossRef
33.
Zurück zum Zitat Khan N, Williams BB, Hou H et al (2007) Repetitive tissue pO2 measurements by electron paramagnetic resonance oximetry: current status and future potential for experimental and clinical studies. Antioxid Redox Signal 9:1169–1182PubMedCrossRef Khan N, Williams BB, Hou H et al (2007) Repetitive tissue pO2 measurements by electron paramagnetic resonance oximetry: current status and future potential for experimental and clinical studies. Antioxid Redox Signal 9:1169–1182PubMedCrossRef
34.
36.
Zurück zum Zitat Jordan B, Baudelet C, Gallez B (1998) Carbon-centered radicals as oxygen sensors for in vivo electron paramagnetic resonance: screening for an optimal probe among commercially available charcoals. MAGMA 7(2):121–129PubMedCrossRef Jordan B, Baudelet C, Gallez B (1998) Carbon-centered radicals as oxygen sensors for in vivo electron paramagnetic resonance: screening for an optimal probe among commercially available charcoals. MAGMA 7(2):121–129PubMedCrossRef
37.
Zurück zum Zitat Lan M, Beghein N, Charlier N, Gallez B (2004) Carbon blacks as EPR sensors for localized measurements of tissue oxygenation. Magn Reson Med 5:1272–1278CrossRef Lan M, Beghein N, Charlier N, Gallez B (2004) Carbon blacks as EPR sensors for localized measurements of tissue oxygenation. Magn Reson Med 5:1272–1278CrossRef
38.
Zurück zum Zitat Swartz HM, Clarkson RB (1998) The measurement of oxygen in vivo using EPR techniques. Phy Med Biol 43:1957–1975CrossRef Swartz HM, Clarkson RB (1998) The measurement of oxygen in vivo using EPR techniques. Phy Med Biol 43:1957–1975CrossRef
39.
Zurück zum Zitat Hou H, Khan N, O’Hara JA et al (2005) Increased oxygenation of intracranial tumors by Efaproxyn™ (efaproxiral), an allosteric hemoglobin modifier: an in vivo EPR oximetry study. Int Radiat Onc Biol Phys 61:1503–1509CrossRef Hou H, Khan N, O’Hara JA et al (2005) Increased oxygenation of intracranial tumors by Efaproxyn™ (efaproxiral), an allosteric hemoglobin modifier: an in vivo EPR oximetry study. Int Radiat Onc Biol Phys 61:1503–1509CrossRef
40.
Zurück zum Zitat Hou H, Khan N, Grinberg O et al (2007) The effects of Efaproxyn™ (efaproxiral) on subcutaneous RIF-1 tumor oxygenation and enhancement of radiotherapy mediated tumor growth inhibition in mice. Radiat Res 168:218–225PubMedCrossRef Hou H, Khan N, Grinberg O et al (2007) The effects of Efaproxyn™ (efaproxiral) on subcutaneous RIF-1 tumor oxygenation and enhancement of radiotherapy mediated tumor growth inhibition in mice. Radiat Res 168:218–225PubMedCrossRef
41.
Zurück zum Zitat Grinberg OY, Hou H, Swartz HM (2001) Direct repeated measurements of PO2 in the brain during ischemia and reperfusion. In: Fukuuchi Y, Tomita M, Koto A (eds) Ischemic blood flow in the brain. Keio University Symposia for Life Science and Medicine, vol 6. Springer, Tokyo, p 381–389 Grinberg OY, Hou H, Swartz HM (2001) Direct repeated measurements of PO2 in the brain during ischemia and reperfusion. In: Fukuuchi Y, Tomita M, Koto A (eds) Ischemic blood flow in the brain. Keio University Symposia for Life Science and Medicine, vol 6. Springer, Tokyo, p 381–389
42.
Zurück zum Zitat Hou H, Grinberg O, Williams B et al (2007) Effect of oxygen therapy on brain damage and cerebral pO2 in transient focal cerebral ischemia in the rat. Physiol Meas 28:963–976PubMedCrossRef Hou H, Grinberg O, Williams B et al (2007) Effect of oxygen therapy on brain damage and cerebral pO2 in transient focal cerebral ischemia in the rat. Physiol Meas 28:963–976PubMedCrossRef
43.
Zurück zum Zitat Liu KJ, Gast P, Moussavi M et al (1993) Lithium phthalocyanine: a probe for EPR oximetry in viable biological systems. Proc Natl Acad Sci 90:5438–5442PubMedPubMedCentralCrossRef Liu KJ, Gast P, Moussavi M et al (1993) Lithium phthalocyanine: a probe for EPR oximetry in viable biological systems. Proc Natl Acad Sci 90:5438–5442PubMedPubMedCentralCrossRef
44.
Zurück zum Zitat Dinguizli M, Jeumont S, Beghein N et al (2006) Development and evaluation of biocompatible films of polytetrafluoroethylene polymers holding lithium phthalocyanine for their use in EPR oximetry. Biosens Bioelectron 21:1015–1022PubMedCrossRef Dinguizli M, Jeumont S, Beghein N et al (2006) Development and evaluation of biocompatible films of polytetrafluoroethylene polymers holding lithium phthalocyanine for their use in EPR oximetry. Biosens Bioelectron 21:1015–1022PubMedCrossRef
45.
Zurück zum Zitat Gallez B (2003) Packaging of paramagnetic materials in oximetry and other applications. In: Berliner L (ed) In vivo EPR (ESR): theory and application. Springer, Boston, MA, p 259–284 Gallez B (2003) Packaging of paramagnetic materials in oximetry and other applications. In: Berliner L (ed) In vivo EPR (ESR): theory and application. Springer, Boston, MA, p 259–284
46.
Zurück zum Zitat Schaner PE, Pettus JR, Flood AB et al (2020) OxyChip implantation and subsequent electron paramagnetic resonance oximetry in human tumors is safe and feasible: first experience in 24 patients. Front Oncol 10:572060PubMedPubMedCentralCrossRef Schaner PE, Pettus JR, Flood AB et al (2020) OxyChip implantation and subsequent electron paramagnetic resonance oximetry in human tumors is safe and feasible: first experience in 24 patients. Front Oncol 10:572060PubMedPubMedCentralCrossRef
47.
Zurück zum Zitat Schaner PE, Williams BB, Chen EY et al (2021) First-in-human study in cancer patients establishing the feasibility of oxygen measurements in tumors using electron paramagnetic resonance with the OxyChip. Front Oncol 11:1–16CrossRef Schaner PE, Williams BB, Chen EY et al (2021) First-in-human study in cancer patients establishing the feasibility of oxygen measurements in tumors using electron paramagnetic resonance with the OxyChip. Front Oncol 11:1–16CrossRef
48.
Zurück zum Zitat Caston RW, Schreiber W, Hou H et al (2017) Development of the implantable resonator system for clinical EPR oximetry. Cell Biochem Biophys 75:275–283PubMedPubMedCentralCrossRef Caston RW, Schreiber W, Hou H et al (2017) Development of the implantable resonator system for clinical EPR oximetry. Cell Biochem Biophys 75:275–283PubMedPubMedCentralCrossRef
49.
Zurück zum Zitat Chen EY, Tse D, Hou H et al (2021) Evaluation of a refined implantable resonator for deep-tissue EPR oximetry in the clinic. Appl Magn Reson 52:1321–1342PubMedPubMedCentralCrossRef Chen EY, Tse D, Hou H et al (2021) Evaluation of a refined implantable resonator for deep-tissue EPR oximetry in the clinic. Appl Magn Reson 52:1321–1342PubMedPubMedCentralCrossRef
50.
Zurück zum Zitat Hou H, Khan N, Du G et al (2016) Temporal variation in the response of tumors to hyperoxia with breathing carbogen and oxygen. Med Gas Res 6:138–146PubMedPubMedCentralCrossRef Hou H, Khan N, Du G et al (2016) Temporal variation in the response of tumors to hyperoxia with breathing carbogen and oxygen. Med Gas Res 6:138–146PubMedPubMedCentralCrossRef
51.
Zurück zum Zitat Swartz HM, Williams BB, Hou H et al (2016) Direct and repeated clinical measurements of pO2 for enhancing cancer therapy and other applications. Adv Exp Med Biol 923:95–104PubMedPubMedCentralCrossRef Swartz HM, Williams BB, Hou H et al (2016) Direct and repeated clinical measurements of pO2 for enhancing cancer therapy and other applications. Adv Exp Med Biol 923:95–104PubMedPubMedCentralCrossRef
52.
Zurück zum Zitat Jeong JJ, Liu T, Yang X et al (2019) Measurements of normal tissue oxygenation via electron paramagnetic resonance (EPR) oximetry during and after breast radiation therapy: baseline evaluations and response to hyperoxygenation. Radiol Radiat Ther 7(1082):1–6 Jeong JJ, Liu T, Yang X et al (2019) Measurements of normal tissue oxygenation via electron paramagnetic resonance (EPR) oximetry during and after breast radiation therapy: baseline evaluations and response to hyperoxygenation. Radiol Radiat Ther 7(1082):1–6
53.
Zurück zum Zitat Kaanders JHAM, Pop LAM, Marres HAM et al (2002) ARCON: experience in 215 patients with advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 52(3):769–778PubMedCrossRef Kaanders JHAM, Pop LAM, Marres HAM et al (2002) ARCON: experience in 215 patients with advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 52(3):769–778PubMedCrossRef
54.
Zurück zum Zitat Gilbert MR, Dignam JJ, Armstrong TS et al (2014) A randomized trial of bevacizumab for newly diagnosed glioblastoma. N Engl J Med 370(8):699–708PubMedPubMedCentralCrossRef Gilbert MR, Dignam JJ, Armstrong TS et al (2014) A randomized trial of bevacizumab for newly diagnosed glioblastoma. N Engl J Med 370(8):699–708PubMedPubMedCentralCrossRef
55.
Zurück zum Zitat Overgaard J (2007) Hypoxic radiosensitization: adored and ignored. J Clin Oncol 25(26):4066–4074PubMedCrossRef Overgaard J (2007) Hypoxic radiosensitization: adored and ignored. J Clin Oncol 25(26):4066–4074PubMedCrossRef
Metadaten
Titel
Re-examining What the Results of “a Measurement of Oxygen Level in Tissues” Really Mean
verfasst von
Harold M. Swartz
Ann Barry Flood
Publikationsdatum
04.01.2024
Verlag
Springer International Publishing
Erschienen in
Molecular Imaging and Biology
Print ISSN: 1536-1632
Elektronische ISSN: 1860-2002
DOI
https://doi.org/10.1007/s11307-023-01887-6

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärzte und Psychotherapeuten.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.